Anson Funds Management LP

Insider Reports History

Entity: Company
Location: 16000 Dallas Parkway, Suite 800, Dallas, TX
Signature: /s/ Tony Moore, manager of Anson Management GP LLC, general partner of Anson Funds Management LP
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Anson Funds Management LP:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
MEI Pharma, Inc.	10%+ Owner	Common Stock	1.09M	$7.65M	$7.00	Oct 20, 2023	Indirect
Trilogy International Partners Inc.	10%+ Owner	Common Shares, no par value	8.98M			Dec 20, 2023	Indirect
MEI Pharma, Inc.	10%+ Owner	Put Option (obligation to buy)	0			Oct 20, 2023	Indirect

Showing 1 to 3 of 3 entries

Insider Reports Filed by Anson Funds Management LP

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
TRLH	Trilogy International Partners Inc.	Nov 14, 2023	4	-$29.9K	4	Feb 26, 2024	10%+ Owner
MEIP	MEI Pharma, Inc.	Oct 20, 2023	5	$1.25M	4	Oct 24, 2023	10%+ Owner
MEIP	MEI Pharma, Inc.	Oct 11, 2023	4	$350K	4	Oct 13, 2023	10%+ Owner
MEIP	MEI Pharma, Inc.	Sep 22, 2023	2	$328K	4	Sep 25, 2023	10%+ Owner
MEIP	MEI Pharma, Inc.	Sep 20, 2023	2	$938K	4	Sep 22, 2023	10%+ Owner
MEIP	MEI Pharma, Inc.	May 19, 2023	0	$0	3	May 30, 2023	10%+ Owner
TRL.H	Trilogy International Partners Inc.	Jan 1, 2023	0	$0	3	Jan 13, 2023	10%+ Owner